Medicine’s Bruce Sherman examines racial disparities related to specialized biologic pharmaceutical prescriptions

Black and Hispanic patients with autoimmune disorders less likely to be prescribed specialty drugs, study finds

Managed Healthcare Executive: In a recent study, Bruce Sherman, clinical assistant professor of medicine at the School of Medicine, showed that, among workers making the same amounts, fewer Black and Hispanic patients received specialized biologic pharmaceutical prescriptions than did White patients. “Employer efforts to manage SpRx [specialty drug] costs by implanting increased cost sharing from enrollees have contributed to disparities in the use of these medications with a lower prevalence of SpRx use among low-wage earners with autoimmune conditions,” he said.